Drug Shortage Report for SANDOZ TAMSULOSIN CR
| Report ID | 182582 |
| Drug Identification Number | 02340208 |
| Brand name | SANDOZ TAMSULOSIN CR |
| Common or Proper name | TAMSULOSIN CR |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100PRT |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-25 |
| Estimated end date | 2023-02-24 |
| Actual end date | 2023-02-17 |
| Shortage status | Resolved |
| Updated date | 2023-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-03-02 | French | Compare |
| v4 | 2023-03-02 | English | Compare |
| v3 | 2023-01-27 | French | Compare |
| v2 | 2023-01-27 | English | Compare |
| v1 | 2023-01-27 | English | Compare |
Showing 1 to 5 of 5